Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent

ABSTRACT

The present invention relates to the use of a taste masking agent selected from the group of starch; cellulose; xanthan gum; gellan gum; alginate; galactomannans such as fenugreek, guar gum, tara gum, locust bean gum, and cassia gum; gum karaya; gum tragacanth; carrageenan; and mixture thereof, for improving one or more of mouth feel, taste, aftertaste and smell of a liquid aqueous nutritional composition comprising a nucleoside and/or a nucleotide. It also relates to a nutritional composition comprising an unsavory nucleoside and/or nucleotide component, having improved sensory characteristics such as improved mouth feel, taste, aftertaste and smell. In particular, it relates to a composition comprising said unsavory nucleoside and/or nucleotide component, in particular comprising an uridine-containing nucleoside and/or a nucleotide in combination with an unsavory edible oil, such as a fish oil.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Continuation of patent application Ser. No.14/095,676, which is a Continuation of patent application Ser. No.12/809,431, filed as the National Phase of International PatentApplication No. PCT/NL2008/050843, filed Dec. 22, 2008, published as WO2009/082227, which claims priority to PCT/NL2008/050124, filed Mar. 4,2008 and European Application No. 07123811.7, filed Dec. 20, 2007. Thecontents of these applications are herein incorporated by reference intheir entirety.

FIELD OF THE INVENTION

The present invention relates to the use of a taste masking agent forimproving one or more of mouth feel, taste, aftertaste and smell of aliquid aqueous nutritional composition comprising a nucleoside and/or anucleotide. It also relates to a liquid aqueous nutritional compositioncomprising a nucleoside and/or nucleotide component, having improvedsensory characteristics such as improved mouth feel, taste, aftertasteand smell. In particular, it relates to a composition comprising anucleoside and/or nucleotide component, in particular comprising anuridine-containing nucleoside and/or a nucleotide in combination with anunsavoury edible oil, such as a fish oil.

BACKGROUND OF THE INVENTION

Memory loss, dementia and reduced brain function are major problems,particularly in elderly. Significant effort is put in the treatmentand/or prevention of these disorders related with impaired nervefunctioning. Persons older than 50 years of age are particularly proneto developing such disorders.

One way to tackle the problem is the administration of anuridine-containing nucleoside and/or nucleotide, preferably in the formof a nutritional composition.

WO2006/031683 (MIT, 23 Mar. 2006) teaches to administer a compositioncomprising uridine or a source of uridine, thereby inhibiting orpreventing a decline in a cognitive function in a subject, wherein saiddecline is a result of a cardiovascular disease, neurodegenerativedisease, or psychiatric disease. Uridine, in particular in the form ofuridine monophosphate (UMP), is a nutrient that increases synthesis andrelease of neurotransmitters and membrane synthesis by neural cells andbrain cells. Nutritional products containing uridine and highconcentrations of macro- and micronutrients are administered to elderlypatients, with the aim to prevent memory decline.

However, when targeting this group of patients often troubled by reducedappetite or disturbed eating behaviour, such a nutritional product needsto satisfy a number of requirements. It should be readily consumable,thus avoiding an insufficient intake of the active ingredients. For thatpurpose, it is strived for a product that is desirably palatable andwhich has a sufficiently low viscosity so it can be easily swallowed.

It is desirable to administer active ingredients to elderly andAlzheimer patients in liquid form. Furthermore, it is highly desirableto administer the active ingredients in a relatively small dosage formsuch that the administration does not interfere with normal nutritionalintake. Additionally palatability is of utmost importance to ensurecompliance products need to be consumed for many day, weeks, months oryears.

Hence, based on the knowledge that nucleosides/nucleotides, particularlyuridine- and/or cytidine-containing nucleotides, are advantageously usedby patients suffering from memory impairment, the present inventorsdesigned a liquid composition containing uridine monophosphate suitablefor administration to elderly and Alzheimer patients, i.e. a liquidcomposition prepared by admixing different ingredients including a largeamount of uridine monophosphate, edible oils, proteins and preferablyalso minerals.

However, unexpectedly, the uridine- and/or cytidine-containingnucleotides, in particular the nutritional composition comprising saiduridine- and/or cytidine-containing nucleotides had a unpleasant taste,as further characterised by Qualitative Descriptive Analysis (QDA).Uridine as such is rated as “very bitter”, uridine monophosphate israted as “sickly” or “salty”. It is the first time that this problem isrecognized in the art for this type of product, high in nucleotidesand/or nucleosides.

The problem is further aggravated by the fact that the product inquestion preferably contains a fish oil, having a fishy taste and smellof its own, which is—in combination with the taste of the uridine-and/or cytidine-containing nucleotides experienced as off-tastes like“oily” and “sickly”.

Unexpectedly, it was found that mouth feel, taste, aftertaste and smellof a liquid aqueous nutritional composition comprising a nucleosideand/or a nucleotide, and optionally an unsavoury edible oil, inparticular a fish oil, could be improved considerably with the use of ataste masking agent selected from the group of starch; cellulose;xanthan gum; gellan gum; alginate; galactomannans such as fenugreek,guar gum, tara gum, locust bean gum, and cassia gum; gum karaya; gumtragacanth; carrageenan; and mixture thereof.

SUMMARY DESCRIPTION OF THE INVENTION

In one aspect, the present invention is concerned with the use of ataste masking agent selected from the group of starch; cellulose;xanthan gum; gellan gum; alginate; galactomannans such as fenugreek,guar gum, tara gum, locust bean gum, and cassia gum; gum karaya; gumtragacanth; carrageenan; and mixture thereof, for improving one or moreof mouth feel, taste, aftertaste and smell of a liquid aqueousnutritional composition comprising a nucleoside and/or a nucleotide.Most preferably, the taste masking agent is cellulose.

According to the invention, an improved mouth feel, taste, aftertasteand smell can be qualitatively determined using a QDA panel test whichdefines and rates mouth feel, taste, aftertaste and smell in aformulation.

It can also be determined in a consumer panel score, and can beexpressed as a higher score for overall liking as defined and explainedin the experimental section.

In a further aspect, the present invention is concerned with theaforementioned use, wherein the nucleoside is selected from the group ofadenosine, guanosine, uridine, cytidine, thymidine, inosine, derivativesthereof, and mixtures thereof and/or the nucleotide is selected from thegroup of adenosine monophosphate (AMP), adenosine diphosphate (ADP),adenosine triphosphate (ATP), guanosine monophosphate (GMP), guanosinediphosphate (GDP), guanosine triphosphate (GTP), uridine monophosphate(UMP), uridine diphosphate (UDP), uridine triphosphate (UTP), cytidinemonophosphate (CMP), cytidine diphosphate (CDP), and cytidinetriphosphate (CTP), and mixtures thereof.

In a further aspect, the present invention is concerned with theaforementioned use, wherein the liquid composition further comprises anunsavoury edible oil, in particular a fish oil. Preferably, the fish oilcomprises at least one omega-3 fatty acid selected from the group ofdocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).

DETAILED DESCRIPTION OF THE INVENTION

Taste Masking Agent

The present composition according to the invention contains a tastemasking agent. Preferably, the present composition contains a tastemasking agent selected from the group consisting of starch; cellulose;xanthan gum; gellan gum; alginate; galactomannans such as fenugreek,guar gum, tara gum, locust bean gum, and cassia gum; gum karaya; gumtragacanth; carrageenan; and mixture thereof.

More preferably, the present composition comprises a taste masking agentselected from the group consisting of xanthan gum, gellan gum andcellulose, and mixture thereof. Said taste masking agent preferably haveshear-thinning and/or thixotropic properties which are consideredbeneficial to the formulation or product they are used in. It is evenmore preferred that the taste masking agent is selected from the groupconsisting of xanthan gum and cellulose. Most preferably, the presentcomposition comprises cellulose.

According to a special embodiment, the taste masking agent comprises acombination of starch and at least one compound selected from the groupof cellulose, cellulose derivatives, xanthan gum, gellan gum, alginate,guar gum, locust bean gum, gum karaya, gum tragacanth, carrageenan,alginic acid and thereof. Said combination has been disclosed in WO2001/32034 (Smithkline Beecham, 10 May 2001) for masking the taste of anunpalatable edible marine oil. The use of said combination for improvingone or more of mouth feel, taste, aftertaste and smell of a liquidaqueous nutritional composition comprising a nucleoside and/or anucleotide, has not been suggested nor disclosed therein.

According to a preferred embodiment, the present composition contains atleast 70 weight % of cellulose based on total weight of taste maskingagent.

Preferably, the present composition contains between 0.05 and 3 weight %of one or more of the aforementioned taste masking agents according tothe invention, based on total weight of the composition, preferablybetween 0.1 and 2 weight %, more preferably between 0.3 and 1 weight %.

One of the preferred taste masking agents is starch. Starch isobtainable from a variety of sources, such as, for instance, corn/maize,high amylase maize, waxy maize, potato, rice and wheat, and the starchmay be in a pregeletinized or non-pregeletinized form.

Generally preferred are those taste masking agents which arepseudoplastic, such as xanthan, gellan and cellulose.

One of the preferred taste masking agents is the polysaccharide xanthangum. Its backbone consists of two β-D-glucose units linked through the 1and 4 positions. The side chain consists of two mannose and oneglucuronic acid, so the chain consists of repeating modules of fivesugar units. The side chain is linked to every other glucose of thebackbone at the 3 position. About half of the terminal mannose unitshave a pyruvic acid group linked as a ketal to its 4 and 6 positions.The other mannose unit has an acetyl group at the 6 positions. It ispreferred to use xanthan gum having pseudoplastic behaviour, and whichis stable over a wide range of temperatures and pH.

Gellan gum is a linear tetrasaccharide4)-L-rhamnopyranosyl-(α-1→3)-D-glucopyranosyl(β-1→4)-D-glucuronopyranosyl-(β-1→4)-D-glucopyranosyl-(β-1→withO(2) L-glyceryl and O(6) acetyl substituents on the 3-linked glucose. Itis a bacterial exopolysaccharide that is prepared commercially in amanner similar to xanthan gum.

In a preferred embodiment, the composition comprises cellulose.Preferably, the present composition contains between 0.05 and 3 weight %of cellulose, based on total weight of the composition, preferablybetween 0.1 and 2 weight %, more preferably between 0.3 and 1 weight %.Cellulose is a linear homopolymer of anhydroglucose units linkedtogether by beta-D-1,4 glycosidic bonds. It is preferred to selectcellulose from the group consisting of high viscous cellulose andcellulose derivatives such as, for example, hydroxyethyl cellulose,hydroxypropyl methylcellulose (HPMC), carboxymethyl cellulose (CMC),microcrystalline cellulose (MCC) and methyl cellulose.

It was found that excellent results, also in terms of stability, wereobtained using large amounts of the non-ionic cellulose ethermicrocrystalline cellulose.

I was further found that mouth feel, taste, aftertaste and smell of aliquid aqueous nutritional composition according to the inventionimproved over time, giving an excellent shelf life in terms of theaforementioned taste attributes.

The taste masking agent of the invention may also act as a thickener forthe liquid aqueous nutritional composition according to the invention.Said function has been disclosed in our copending applicationPCT/NL2008/050124 which is included herein by reference in its entirety.

In this context, it is important to differentiate between slowingprecipitation of already formed particles and/or viscosity increase onthe one hand, from a decrease in rate and/or prevention of the formationof particles on the other hand. In the present case, it is lessimportant to stabilize already suspended particles. After all, in suchcase the formation of precipitates would still occur, since with timeparticles having a higher mass will reach the bottom of the package. Inorder to solve the problem of the invention, in a main aspect thethickener prevents and/or reduces the formation of the particles, andthus decreases the formation of a sediment on the bottom of a package.

Although the inventors do not wish to be bound by theory, it ishypothesised that the lack of formation of said particles could partlyattribute to an improved mouth feel, taste, aftertaste and smell of theliquid aqueous nutritional composition according to the invention.

Due to the limited water-solubility and/or dispersability of thenon-ionic cellulose ether, it is preferred that the liquid aqueousnutritional composition according to the invention further contains arespectable amount of an anionic polymeric polysaccharide. In apreferred embodiment, the anionic polysaccharide is selected from thegroup consisting of guar gum, carboxymethylcellulose, hemicellulose,pectin, alginate, konjac flour, psyllium, gums from tragacanth, xanthan,karaya, chia, wellan, ghatti or okra, or the hydrolysates of theseoligo- or polycarbohydrates. These anionic polysaccharides facilitatethe manufacture of a stable aqueous food product, in particularly aheat-treated or sterilized liquid product which comprises at least anucleotide, optionally an unsavoury edible oil, such as a marine oil,and one or more proteins and an further edible oil or fat. The anionicpolymeric polysaccharide, such as guar gum or an anionic cellulose,enhances the stability of the aqueous system and preventsaggregation/clothing of cellulose. In one embodiment, it is preferred touse an anionic cellulose, preferably carboxymethyl cellulose (CMC).

In a preferred embodiment, the liquid aqueous nutritional compositionaccording to the invention contains a mixture of MCC and an anionicpolymeric polysaccharide, preferably CMC. The liquid aqueous nutritionalcomposition according to the invention preferably comprises 0.05 to 3.0weight % of a mixture of microcrystalline cellulose (MCC) and an anionicpolymeric polysaccharide, based on the total weight of the composition,preferably 0.05 to 1 weight %, more preferably 0.3 to 1.0 weight %. Therelative weight ratio of non-ionic cellulose to the anionic polymericpolysaccharide is preferably at least 3:1, more preferably between 4:1and 9:1. In one embodiment, it is preferred that at least 70 weight %,more preferably 75 to 90 weight % of the cellulose present in the liquidaqueous nutritional composition according to the invention is providedby MCC. Often, MCC is marketed being coated with CMC or cellulose gum.In the most preferred embodiment, the remainder is formed from CMC.Suitable candidates are Avicel-plus BV2312 and Vivapur MCG591F,commercially available with FMC biopolymers and Rettenmaier,respectively. Particularly good results are reported for the latter ofthe two.

It is further found that optimal characteristics were obtained withtaste masking agents having a certain particle size. Preferably, thepresent taste masking agent is a mixture of particles wherein at least50 weight % of the particles have a particle size between 20 and 200micrometer. The bigger particle sizes avoid sedimentation to occur overlonger time scales.

The inventors have discovered that the amount of cellulose in the liquidaqueous nutritional composition according to the invention is preferablymore than 0.05 weight %, more preferably at least 0.1 weight %, morepreferably at least 0.3 weight %, most preferably about 0.4 weight %,based on the total weight of the composition. It is believed that atthese concentrations a weak three-dimensional network is built whicheffectively holds the components in the liquid matrix, the result beingno sediment can form and a good taste is obtained. In order to controlthe viscosity and taste of the composition, it is preferred that thecomposition contains less than 1.0 weight %, more preferably less than0.8 weight % of the cellulose.

Apart from the cellulose, gellan and/or xanthan thickeners, it ispreferred that the liquid aqueous nutritional composition according tothe invention is low in other thickening agents, i.e. substances thatare known to increase the viscosity of a composition withoutsubstantially modifying its other properties, such as taste. It ispreferred that the composition comprises less than 0.1 weight %, morepreferably less than 0.05 weight % of such other food thickeners, mostpreferably none at all. In one embodiment, the weight ratio of compoundshaving a thickening effect other than cellulose and xanthan over the sumof cellulose and xanthan thickeners of the present invention is lessthan 0.1, preferably less than 0.01, more preferably 0. More preferably,the weight of compounds having a thickening effect other than celluloseover the sum of the weight cellulose thickeners present in thecomposition is less than 0.1, more preferably less than 0.01, mostpreferably 0.

The liquid aqueous nutritional composition according to the inventionpreferably has a low viscosity, preferably a viscosity between 1 and 100mPa·s measured at a shear rate of 100 sec⁻¹ at 20° C. High viscositiesare to be avoided, since these often are associated with unacceptablemouthfeel characteristics and difficulty to be ingested by the targetgroup, e.g. elderly and Alzheimer patients. More preferably, the presentcomposition is preferably provided in the form of a drink capable ofbeing ingested through a straw which makes the product even easier toingest and improves compliance. In a preferred embodiment the presentcomposition has a viscosity of less than 80 mPa·s at a shear rate of 100sec⁻¹ at 20° C., more preferably of 1 to 40 mPa·s at a shear rate of 100sec⁻¹ at 20° C. These viscosity measurements may be performed usingplate and cone geometry. ‘Cone and Plate’ viscometers use a cone of veryshallow angle in bare contact with a flat plate. With this system theshear rate beneath the plate is constant to a modest degree of precisionand deconvolution of a flow curve; a graph of shear stress (torque)against shear rate (angular velocity) yields the viscosity in astraightforward manner.

It is preferred that the liquid aqueous nutritional compositionaccording to the invention fulfils FSMP guidelines, and hence containssignificant amounts of minerals and vitamins. Hence, typically theproduct has an osmolality of 300 to 800 mOsm/kg.

To prevent increased viscosity due to gelling of protein, when present,the pH of the liquid is preferably kept around neutral, while for a goodpalatability the pH is preferably slightly acidic. The liquid aqueousnutritional composition according to the invention preferably has a pHin the range of 5 to 7.5, more preferably 6 to 7.

The liquid aqueous nutritional composition according to the inventionpreferably has a dry matter content in the range of 10 to 40 weight %,more preferably 10 to 30 weight %.

Nucleoside and Nucleotides

The liquid aqueous nutritional composition according to the inventioncomprises a nucleoside and/or nucleotide, preferably a nucleotide. Anucleotide is typically more effectively absorbed by the body.

Within the context of this invention, a nucleoside is a glycosylamineconsisting of a nucleobase bound to a ribose or deoxyribose sugar.Examples of these include cytidine, uridine, adenosine, guanosine,thymidine and inosine, deoxy-derivatives thereof, acylated derivativesthereof, and phosphate derivatives thereof. When a nucleoside isphosphorylated (mono-, di- or tri-), a nucleotide is formed, which isthe molecular building block of DNA and RNA.

The liquid aqueous nutritional composition according to the inventioncomprises at least 50 mg of a nucleotide and/or nucleoside per 100 ml ofcomposition, preferably 80 to 3000 mg of a nucleotide and/or nucleosideper 100 ml of composition, more preferably 100 to 2000 mg of anucleotide and/or nucleoside per 100 ml of composition, most preferably200 to 1000 mg of a nucleotide and/or nucleoside per 100 ml ofcomposition.

Preferably, the liquid aqueous nutritional composition according to theinvention is characterized by comprising predominantly nucleotides overnucleosides. Hence, the weight ratio of nucleotides over nucleosides ispreferably more than 2.0, more preferably more than 4.0, most preferablymore than 10.0, in particular more than 20. These ratios arespecifically preferred for a liquid aqueous nutritional compositionaccording to the invention with a pH between 2.0 and 8.0, morepreferably between 5 and 7.5, more preferably 5.5 and 7.5, mostpreferably 6 and 7.

The present inventors have found that the invention works particularlywell when the liquid aqueous nutritional composition according to theinvention comprises uridine or a uridine nucleotide, preferably auridine nucleotide, preferably at least a uridine nucleotide selectedfrom the group consisting of uridine monophosphate (UMP), uridinediphosphate (UDP), and uridine triphosphate (UTP), or mixtures thereof.

Also, the liquid aqueous nutritional composition according to theinvention may comprises cytidine or a cytidine nucleoside, preferably acytidine nucleotide, preferably at least a cytidine phosphate selectedfrom the group consisting of cytidine monophosphate (CMP), cytidinediphosphate (CDP), and cytidine triphosphate (CTP), or mixtures thereof.

Most preferably, the liquid aqueous nutritional composition according tothe invention comprises UMP, as UMP is most efficiently being taken upby the body. Additionally, it was surprisingly found by the inventorsthat UMP contributes to the product stability, since it binds calciumand thus reduces calcium-induced protein aggregation even further.

Hence, inclusion of UMP in the liquid aqueous nutritional compositionaccording to the invention enables a high efficacy at the lowest dosageand/or the administration of a low volume to the subject. Preferably, atleast 50 weight % of the uridine in the liquid aqueous nutritionalcomposition according to the invention is provided by UMP, morepreferably at least 75 weight %, most preferably at least 95 weight %.The liquid aqueous nutritional composition according to the inventionpreferably comprises 0.08 to 3 g uridine per 100 ml of composition,preferably 0.1 to 2 g uridine per 100 ml of composition, more preferably0.2 to 1 g uridine per 100 ml of composition.

The liquid aqueous nutritional composition according to the inventionpreferably comprises 0.08 to 3 g UMP per 100 ml of composition,preferably 0.1 to 2 g UMP per 100 ml of composition, more preferably 0.2to 1 g per 100 ml of composition.

Preferably, the weight ratio of uridine to cytidine is larger than 1.0,more preferably at least 2.0, most preferably more than 5.0. Althoughcytidine is a precursor of uridine, which passes the blood brainbarrier, it is more efficient and effective to include uridine in thepresent composition.

In a further preferred embodiment, the liquid aqueous nutritionalcomposition according to the invention preferably does not contain highamounts of other nucleotides. Hence, preferably the weight ratio ofadenosine to uridine in the present composition is below 0.1, morepreferably below 0.01, most preferably 0. Preferably the weight ratio ofguanosine to uridine in the present composition is below 0.1, morepreferably below 0.01, most preferably 0. Preferably the weight ratio ofinosine to uridine in the present composition is below 0.1, morepreferably below 0.01, most preferably 0.

Unsavoury Edible Oil

The liquid aqueous nutritional composition according to the inventionpreferably contains an unsavoury edible oil that is suitably of animal,vegetable or mineral origin. Animal oils are generally derived from theorgans and tissues of animals; vegetable oils are commonly derived fromplant seeds. Illustrative non-limiting examples of oils include animaloils such as a marine oil such as seal oil, whale oil, krill oil, fishoil such as capelin oil, fish liver oil, e.g. cod liver oil, and fishoils produced from additional body parts (also referred to as fishoils); and vegetable oils such as algae oil, castor oil, soybeen oil,corn oil and linseed oil.

Preferably, the unsavoury edible oil is a fish oil comprisingdocosahexaenoic acid (22:6 ω-3; DHA), and/or eicosapentaenoic acid (20:5ω-3; EPA). Therefore, the liquid aqueous nutritional compositionaccording to the invention comprises at least one omega-3 fatty acidselected from the group of docosahexaenoic acid (DHA) andeicosapentaenoic acid (EPA). The liquid aqueous nutritional compositionaccording to the invention preferably comprises 100 to 5000 mg per 100ml of the sum of one or more of docosahexaenoic acid (DHA) andeicosapentaenoic acid (EPA), more preferably 500 to 3000 mg per 100 mlof composition. This means that preferably at least one ofdocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) is present inthe composition according to the invention, whereby the concentration ofDHA alone, EPA alone or the sum of EPA and DHA preferably is 100 to 5000mg per 100 ml, more preferably 500 to 3000 mg per 100 ml of composition.

The present composition preferably contains a very low amount ofarachidonic acid (AA; 20:4 ω-6). Preferably the weight ratio DHA/AA inthe present composition is at least 5, preferably at least 10, morepreferably at least 15. The ratio omega-6/omega-3 fatty acids in thepresent product is preferably below 0.5, more preferably below 0.2.

Protein

The liquid aqueous nutritional composition according to the inventioncomprises protein, preferably intact protein. Proteins enable themanufacturing of palatable products. Especially elderly and AD patientsbenefit from the protein as it strengthens their motor skills.Preferably, the liquid aqueous nutritional composition according to theinvention comprises milk protein. Preferably, the liquid aqueousnutritional composition according to the invention comprises a proteinselected from the group consisting of whey protein, casein or caseinate.Preferably, the liquid aqueous nutritional composition according to theinvention comprises caseinate, more preferably the liquid aqueousnutritional composition according to the invention comprises at least 70weight %, more preferably at least 90 weight % casein and/or caseinate,based on total protein.

Preferably, the proteins are included in intact (unhydrolyzed) form, inorder to have a palatable product. Such high molecular weight proteinsincrease the viscosity of the heat-treated liquid product, compared tothe hydrolyzed forms. The present inventors were able to make anacceptable product, with good palatability and limited viscosity, byapplying the measures according the invention, still avoidingprecipitation.

Preferably, the liquid aqueous nutritional composition according to theinvention comprises between 0.2 and 10 gram protein per 100 ml,preferably between 1 and 6 grams protein per 100 ml, more preferablybetween 2 and 5 grams protein per 100 ml.

Other Components

Preferably, the liquid aqueous nutritional composition according to theinvention further comprises one or more other components, preferably oneor more of a mineral, a phospholipid, a digestible carbohydrate, anorganic acid, an edible fat other than the unsavoury edible oil, anindigestible carbohydrate, a preservative, a colorant, and a flavouringagent.

Minerals

To fulfil important nutritional requirements, the liquid aqueousnutritional composition according to the invention comprises divalentcations, particularly calcium. Preferably, the liquid aqueousnutritional composition according to the invention comprises 10 to 150mg calcium per 100 kcal, preferably 40 to 100 mg calcium per 100 kcal.Alternatively or additionally, it is preferred for the liquid aqueousnutritional composition according to the invention to contain 10 to 150mg calcium per 100 ml, more preferably 40 to 100 mg calcium per 100 ml.The calcium causes particular problems in the aggregation of proteins.Hence, the liquid aqueous nutritional composition according to theinvention preferably comprises an insoluble calcium source. In apreferred embodiment, the calcium salt (s) used in the liquid aqueousnutritional composition according to the invention have a solubilitybelow 0.15 gram per 100 ml, more preferably below 0.1 gram per 100 ml,even more preferably below 0.06 gram per 100 ml (demineralised) water at20° C. and pH 7.

The calcium salt is preferably selected from the group consisting ofcalcium carbonate, calcium sulphate, calcium citrate (e.g. mono-calciumcitrate or tri-calcium citrate), a calcium salt coated with a substancewhich has limited solubility in water at pH 7 and is soluble at a pHbelow about 5 (hereafter referred to as coated calcium salts) andmixtures thereof. Examples of coatings and methods for the preparationsof coated calcium salts are given in W00/038829, the entire content ofwhich is hereby incorporated by reference. Preferably the liquid aqueousnutritional composition according to the invention comprises calciumcitrate.

In certain embodiments, particularly for compositions containing lowamounts of nucleotides or nucleosides, it is be desirable to addphosphate salts. The phosphate salt can be added to provide the mineralrequirements to a patient. Preferably, the liquid aqueous nutritionalcomposition according to the invention contains phosphate salts ofsodium, potassium, calcium and/or magnesium. The liquid aqueousnutritional composition according to the invention preferably comprises30 to 80 mg phosphorus per 100 kcal.

Phospholipids

Preferably, the liquid aqueous nutritional composition according to theinvention comprises a phospholipid, preferably 0.1 to 50 weight %phospholipids, based on total weight of lipids, more preferably 0.5 to20 weight %, more preferably between 1 and 5 weight %, based on totalweight of lipids. Preferably, the liquid aqueous nutritional compositionaccording to the invention contains at least one selected from the groupconsisting of phosphatidylcholine, phosphatidylethanolamine,phosphatidylserine and phosphatidylinositol. The total amount of lipidsis preferably between 10 and 30 weight % on dry matter, and/or between 2and 6 g lipid per 100 ml for a liquid composition. Inclusion ofphospholipids improve the stability of the liquid aqueous nutritionalcomposition according to the invention.

Digestible Carbohydrates

Advantageously, the liquid aqueous nutritional composition according tothe invention comprises digestible carbohydrates. The digestiblecarbohydrates positively influence the operational skills of a subject,and add to the advantageous effect of the liquid aqueous nutritionalcomposition according to the invention. The liquid aqueous nutritionalcomposition according to the invention preferably contains between 1 and50 gram digestible carbohydrates per 100 ml of a liquid product, morepreferably between 5 and 30 grams per 100 ml, more preferably 10 to 30grams of carbohydrates per 100 ml. The total amount of digestiblecarbohydrates is preferably between 25 and 80 weight % on dry matterbasis, preferably 40 to 80 weight %.

Organic Acid

Preferably, the liquid aqueous nutritional composition according to theinvention comprises an organic acid, preferably 0.5 to 10 weight %organic acid(s) based on total weight of digestible carbohydrates, morepreferably 1.5 to 6 weight %. Preferably, the liquid aqueous nutritionalcomposition according to the invention contains citric acid, preferably0.5 to 10 weight % citric acid based on total weight of digestiblecarbohydrates, more preferably 1.5 to 6 weight %.

Other Edible Fat

With regard to the type of fat, other than the aforementioned unsavouryedible fat, a wide choice is possible, as long as the fat is of foodquality. The fat may include medium chain triglycerides (MCT, mainly 8to 10 carbon atoms long), long chain triglycerides (LCT) or anycombination of the two types. MCTs are beneficial because they areeasily absorbed and metabolized. Moreover, the use of MCTs will reducethe risk of nutrient malabsorption. LCT sources, such as rapeseed oil,more in particular rapeseed oil low in erucic acid, sunflower oil, cornoil, palm kernel fat, coconut fat, palm oil, or mixtures thereof arepreferred because they provide more energy per unit of fat. In oneembodiment, the fat is a liquid fat, i.e. an oil.

Indigestible Carbohydrate

The liquid enteral nutritional composition according to the inventionmay optionally be fortified with non-digestible carbohydrates (dietaryfibres) such as oligosaccharides.

These oligosaccharides may comprise fructo-oligosaccharides (FOS),galacto-oligosaccharides (GOS), trans-galacto-oligosaccharides (TOS),xylo-oligosaccharides (XOS), soy oligosaccharides, and the like.Optionally, also higher molecular weight compounds such as inulin,resistant starch and the like may be incorporated in the compositionaccording to the invention. In another embodiment of the presentinvention, the composition according to the invention may comprise amixture of neutral and acid oligosaccharides as disclosed in WO2005/039597 (N.V. Nutricia), which is incorporated herein by referencein its entirety.

Flavouring Agent

The nutritional composition according to the invention may also containa flavouring agent, either natural, artificial or a mixture thereof. Theincorporation of a flavouring agent increases the palatability of thenutritional composition according to the invention, so facilitating itsingestion and imparting a pleasant taste to the nutritional composition.Although the nutritional composition according to the invention withouta flavouring agent already tastes pleasant, adding a flavouring agent toimpart a particular flavour may further improve the palatability, thusincreasing patient compliance. Often used flavours are chocolate,vanilla, coffee, caramel, cinnamon, strawberry, lemon, peach, orange,forest fruits, creamy flavour, nutty, coconut, etc. The nutritionalcomposition according to the invention may also contain an artificialsweetener, such as, for instance saccharin, aspartame and the like.Other embodiments will be clear to those skilled in the art. Aparticular preferred flavouring agent is selected from the group ofvanilla, creamy flavour, nutty, coconut and caramel. Suitableflavourings may be used, individually or as a mixture, in an amountranging from about 0.005 weight % to about 2.0 weight % of thecomposition, preferably in an amount of less than 1 weight %. Amountscan be easily determined by the skilled person and depend on theapplication, taste requirements, etc.

Further Features

Persons suffering from neuropathies or neurological problems oftenexperience problems with eating. Their sensory capabilities and/orcontrol of muscles has become imparted, as well as in some instancestheir ambition to apply proper eating habits. Part of these patients mayexperience a general loss in appetite and a relatively large part ofthis patient group became malnourished. Preferably the product has anenergy density of 0.8 to 4.5 kcal per gram of the composition, morepreferably between 0.9 and 2.5 kcal per ml.

Liquid nutritional products preferably have a long shelf life. However,increasing shelf life by heat treatments often results indestabilisation of the products and/or palatability, leading to aproduct which is unacceptable. The liquid aqueous nutritionalcomposition according to the invention can be subjected to a heattreatment without major adverse effects on the palatability. Hence, theliquid aqueous nutritional composition according to the invention ispreferably heat-treated, more preferably the composition is subjected toa sterilization process. In a preferred embodiment, the liquid aqueousnutritional composition according to the invention is subjected to anultra-high temperature treatment (UHT-process). Such UHT-process ispreferably applied in line, i.e. before the liquid final product isfilled in the package of the sold unit.

Application

Although the invention in a particular embodiment pertains in particularto the use of the liquid composition according to the invention forpreventing and/or treating neurodegenerative disorders, preferablyselected from the group consisting of memory decline and/or cognitivedysfunction, Alzheimer's, Parkinson's and/or dementia, and in particularto the use of the composition according to the invention for promotingor supporting healthy brain function, it also pertains in general to anycomposition comprising a unsavoury nucleoside and/or nucleotidecomponent, in particular comprising an uridine-containing nucleosideand/or a nucleotide in combination with an unsavoury edible oil, such asa fish oil, for any particular use.

The composition is particularly useful for the dietary management ofsubjects suffering from neurodegenerative disorders, preferably selectedfrom the group consisting of memory decline and/or cognitivedysfunction, Alzheimer's, Parkinson's and/or dementia.

The present composition is preferably administered in doses of between25 and 500 ml of the present composition, preferably between 50 and 250ml, preferably between 75 and 150 ml. Preferably, the composition isadministered once a day. Relatively limited volumes are easy to ingestby the target patients groups, e.g. elderly and AD patients, preferablya person older than 50 years of age.

DESCRIPTION OF FIGURES

FIG. 1: Biplot after Varimax rotation (axes F1 and F2: 87.61%) for thevarious formulations (see Table 2). m=mouth feel; s=smell; t==taste;at=aftertaste.

FIG. 2a : Spider R1 (sold line) versus P2 (dotted line) and FIG. 2b : R1(sold line) versus V2 (dotted line); the * indicates a significantdifferent attribute. m=mouth feel; s=smell; t==taste; at=aftertaste.

FIG. 3: Consumer panel results of four flavor concepts (vanilla,strawberry, cappuccino and peach/orange).

EXPERIMENTAL

Study Design

Qualitative Descriptive Analysis (QDA) was performed on a series offormulations that varied in amount of protein, fat, taste masking agent,and maltodextrin/sucrose ratio (Table 1 for the reference formula andFIG. 1). All batches of the formulation were prepared with orange/peachflavours. The study was conducted as a single blind sip feed evaluationof the formulations on 19 attributes, using a QDA panel with 11 trainedassessors and scoring on 100 mm line scale. This QDA panel generatesattributes (such as fishy, intensity, fruity, sickly, etc.), whichdescribe the product, without indicating if the products are most orleast appreciated (hedonic scale).

Statistical analyses were done using XLSTAT 7.5.2. Principal ComponentAnalysis (PCA) (Addinsoft SARL) using uniform weighting and a varimaxrotation of the axes. Differences are found significant at asignificance level of 0.05 (two-tailed test).

The objective of this research was to analyse if the amount of protein,fat, taste masking agent or maltodextrin/sucrose ratio influences theamount of off-notes (mouth feel, taste, after taste and smell) in theformulation.

The following reference formulation was used (Table 1).

TABLE 1 Ingredients (per 100 ml) Reference Energy 100 kcal Protein(casein/whey 80/20) 3.06 g Carbohydrates 13.3 g includingmaltodextrin/sucrose 7.2 g/6.0 g Fat (fish oil, phospholipids) 3.73 gincluding: 0.96 g DHA 0.24 g EPA Uridine monophosphate (disodium salt)0.5 g Taste masking agent 0 g Choline 0.32 g Vitamin E 32 mg Vitamin C(Alpha-tocopherol) 64 mg Selenium 48 mcg Vitamin B6 0.8 mg Folic acid0.32 mg Vitamin B12 2.4 mcg Magnesium 20 mg Zinc 1.2 mg Manganese 0.3 mgMolybdenum 10 mcg Na 0.1 g K 0.15 g Cl 0.12 g Ca 80 mg P 70 mg Fe 1.6 mgI 27 mcg Cu 0.18 mg Cr 6.7 mcg F 0.1 mg Vitamin A 0.16 mg Vitamin B10.15 mg Vitamin B2 0.16 mg Vitamin B3 1.8 mg Vitamin B5 0.53 mg VitaminD 0.7 mcg Biotin 4.0 mcg Vitamin K 5.3 mcg

Experiment 1

The following formulations were tested (Table 2):

TABLE 2 S-R1 Reference (see Table 1) S-F4 Fish oil replaced by canolaoil S-P2 Protein amount raises up to 6 g/100 ml S-P3 Protein amountraises up to 6 g/100 ml and added an extra 2.3 g/ 100 ml of canola oilS-C3 7.8 g sucrose and 5.4 g maltodextrin S-V2 Added 0.4% cellulose astaste masking agent S-V3 Added 0.8% cellulose as taste masking agent

The QDA results show that, compared to reference S-R1, the addition ofmore protein (S-P2, S-P3) or taste masking agent (S-V2, S-V3) gave lessproduct specific taste, after taste and smell and the so named “sicklytaste” was also clearly reduced. However, addition of extra canola oil(S-P3) or more sucrose than maltodextrin (S-C3) did not contribute tothe reduction of negative attributes.

With addition of protein or taste masking agent the product is thickerand gives a creamier mouth feel. This makes the fat globules lessaccessible to the tongue and nucleotide and fish taste awareness will bereduced. Comparison of the 6 g/100 ml protein batch (S-P2) and 0.4%taste masking agent batch (S-V2) with the reference batch (S-R1) is alsoshown in FIG. 2a and FIG. 2b . No further significant improvements couldbe obtained with addition of higher taste masking agent concentrations(S-V3). Furthermore, a part of the fishy off-notes are (volatile)aldehydes which can bind to e.g. lysine or glutamine. During shelf lifethis binding will increase and the amount of off-notes will decrease,leading to the finding that the palatability increased with increasingshelf life.

In case of addition of more canola oil (S-P3), it was expected that thefish oil would be diluted and consequently the fish taste would bereduced. However, with increase of the oil content, it appears that moreoil is available to be in contact with the tongue surface and as aresult, the fish taste is perceived stronger.

Increased sweetness had a lower impact on the masking off-notes thanaddition of more protein or taste masking agent.

Experiment 2

Four flavour concepts (vanilla, strawberry, cappuccino and peach/orange)of the reference formulation (S-R1) and of the formulation with 0.4% ofcellulose taste masking agent (S-V2) were analysed in an internalconsumer panel. This panel scored products from “dislike very much” to“like very much. Results are summarized in FIG. 3. All flavour variantscontained the same flavours (and concentrations) in all flavourdevelopments, which indicates that addition of 0.4% of cellulose hasincreased the scores, wherein vanilla has the highest score.

CONCLUSION

Addition of extra protein or taste masking agent reduces fish productspecific taste, smell and after taste as well as the “sickly” taste ofthe formulation according to the invention. Flavour development hasshown that addition of 0.4% cellulose increased scores significantly fordifferent flavours.

The invention claimed is:
 1. A liquid composition having a viscositybetween 1 and 100 mPa·s measured at a shear rate of 100 sec-¹ at 20° C.comprising (a) at least 50 mg per 100 ml of composition of uridine,cytidine, and/or a deoxy-, acetylated-, and/or a nucleotide-formthereof, and (b) at least 0.3 wt % of one or more polysaccharidesselected from the group consisting of cellulose; starch; xanthan gum;gellan gum; alginate; galactomannans gum karaya; gum tragacanth; andcarrageenan.
 2. A method of treating a person prone to developing orsuffering from neurodegenerative disorders, the method comprisingadministering to the person the liquid composition having a viscositybetween 1 and 100 mPa·s measured at a shear rate of 100 sec-¹ at 20° C.comprising (a) at least 50 mg per 100 ml of composition of uridine,cytidine, and/or a deoxy-, acetylated-, and/or a nucleotide-formthereof, and (b) at least 0.3 wt % of one or more polysaccharidesselected from the group consisting of cellulose; starch; xanthan gum;gellan gum; alginate; galactomannans gum karaya; gum tragacanth; andcarrageenan.
 3. The liquid composition according to claim 1, wherein thenucleotide-form is selected from uridine monophosphate (UMP), uridinediphosphate (UDP), uridine triphosphate (UTP), cytidine monophosphate(CMP), cytidine diphosphate (CDP), and cytidine triphosphate (CTP), andmixtures thereof.
 4. The liquid composition according to claim 3,comprising UMP in an amount of 0.08 to 3 g per 100 ml of thecomposition.
 5. The liquid composition according to claim 1, wherein thegalactomannans are selected from the group consisting of fenugreek, guargum, tara gum, locust bean gum, and cassia gum.
 6. The liquidcomposition according to claim 1, comprising a cellulose selected fromthe group consisting of high viscous cellulose, hydroxyethyl cellulose,hydroxypropyl methylcellulose (HPMC), carboxymethyl cellulose (CMC),microcrystalline cellulose (MCC) and methyl cellulose.
 7. The liquidcomposition according to claim 6, comprising 0.3 to 3 weight %, based onthe total weight of the composition, of a mixture of MCC and an anionicpolymeric polysaccharide.
 8. The liquid composition according to claim7, wherein the anionic polymeric polysaccharide is carboxymethylcellulose.
 9. The liquid composition according to claim 1, furthercomprising one or more of a protein and a flavouring agent.
 10. Theliquid composition according to claim 9, comprising between 0.2 and 10gram protein per 100 ml.
 11. The liquid composition according to claim9, wherein flavouring agent is selected from the group consisting ofvanilla, creamy flavour, nutty, coconut and caramel.
 12. The liquidcomposition according to claim 1, further comprising a fish oil.
 13. Theliquid composition comprising according to claim 1, further comprisingbetween 100 to 5000 mg of the sum of one or more of docosahexaenoic acidand eicosapentaenoic acid per 100 ml.
 14. A method for treating elderlyprone to or suffering from reduced brain function or memory loss, themethod comprising administering to the elderly the liquid compositionhaving a viscosity between 1 and 100 mPa·s measured at a shear rate of100 sec-1 at 20° C. comprising (a) at least 50 mg per 100 ml ofcomposition of uridine, cytidine, and/or a deoxy-, acetylated-, and/or anucleotide-form thereof, and (b) at least 0.3 wt % of one or morepolysaccharides selected from the group consisting of cellulose; starch;xanthan gum; gellan gum; alginate; galactomannans gum karaya; gumtragacanth; and carrageenan.
 15. A method for promoting or supportinghealthy brain function in a person in need thereof, the methodcomprising administering to the person in need thereof the liquidcomposition having a viscosity between 1 and 100 mPa·s measured at ashear rate of 100 sec-1 at 20° C. comprising (a) at least 50 mg per 100ml of composition of uridine, cytidine, and/or a deoxy-, acetylated-,and/or a nucleotide-form thereof, and (b) at least 0.3 wt % of one ormore polysaccharides selected from the group consisting of cellulose;starch; xanthan gum; gellan gum; alginate; galactomannans gum karaya;gum tragacanth; and carrageenan.
 16. The liquid composition according toclaim 15, comprising UMP in an amount of 0.08 to 3 g per 100 ml of thecomposition.
 17. The liquid composition according to claim 15,comprising 0.3 to 3 weight %, based on the total weight of thecomposition, of a mixture of MCC and carboxymethyl cellulose.
 18. Theliquid composition comprising according to claim 15, further comprisingbetween 100 to 5000 mg of the sum of one or more of docosahexaenoic acidand eicosapentaenoic acid per 100 ml.
 19. The liquid compositionaccording to claim 2, comprising UMP in an amount of 0.08 to 3 g per 100ml of the composition.
 20. The liquid composition according to claim 2,comprising 0.3 to 3 weight %, based on the total weight of thecomposition, of a mixture of MCC and carboxymethyl cellulose.
 21. Theliquid composition comprising according to claim 2, further comprisingbetween 100 to 5000 mg of the sum of one or more of docosahexaenoic acidand eicosapentaenoic acid per 100 ml.
 22. The liquid compositionaccording to claim 14, comprising UMP in an amount of 0.08 to 3 g per100 ml of the composition.
 23. The liquid composition according to claim14, comprising 0.3 to 3 weight %, based on the total weight of thecomposition, of a mixture of MCC and carboxyethyl cellulose.
 24. Theliquid composition comprising according to claim 14, further comprisingbetween 100 to 5000 mg of the sum of one or more of docosahexaenoic acidand eicosapentaenoic acid per 100 ml.